4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-015320
EVP, Head of North America sold 2,035 shares at $57.22 ($116,443)
- EVP, Head of North America acquired 5,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-16 | Option exercise 10b5-1 | +5,500 | 7,893 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-19 | Sale 10b5-1 | −2,035 | $57.22 | $116,443 | 5,858 | D |
| Derivatives | |||||||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-14 | Grant or award · Restricted Stock Units 10b5-1 | +36,650 | 36,650 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-14 | Grant or award · Stock Options (Right to Buy) 10b5-1 | +55,000 | 55,000 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-16 | Option exercise · Restricted Stock Units 10b5-1 | −5,500 | 16,500 | D | ||
| Open-market sales · 2,035 sh · avg $57.22 · $116,443 | |||||||
Loading xslF345X05/tm257103-4_4seq1.xml…